Mehmet SARGIN, MEHMET SELÇUK ULUER, Sadık ÖZMEN

High Dose Sugammadex Administiration in a Case of Huntington Chorea

Huntington Chorea, a central nervues system disease that is inherited autosomal dominantly which causes miscellaneous difficulties and has features by the aspect of anesthesia management. It was aimed to present the first administiration of such high dose sugammadex, in a Huntington Chorea case. Additionally, our case report is the second one in literature

PDF

___

1. MacPherson P, Harper I, MacDonald I. Propofol and remifentanil total intravenous anesthesia for a patient with Huntington disease. J Clin Anesth. 2004;16(7):537-8.

2. Cangemi CF Jr, Miller RJ. Huntington's disease: review and anesthetic case management. Anesth Prog. 1998;45(4):150-3.

3. Davies DD: Abnormal response to anaesthesia in a case of Huntington’s chorea. Br J Anaesth. 1966;38(6):490-1.

4. Rodrigo MR: Huntington’s chorea: midazolam, a suitable induction agent? Br J Anaesth. 1987;59(3):388-9.

5. Johnson MK, Heggie NM: Huntington’s chorea. A role for the newer anaesthetic agents. Br J Anaesth. 1985;57(2):235-6.

6. Khan MH, Banerjee A. Anaesthesia and orphan disease: sugammadex in a patient with Huntington's disease undergoing thyroidlobectomy. Eur J Anaesthesiol. 2012;29(12):593-5.

7. Kivela JE, Sprung J, Southorn PA, Watson JC, Weingarten TN. Anesthetic management of patients with Huntington disease. Anesth Analg. 20101;110(2):515-23.

8. de Boer HD, van Egmond J, van de Pol F, Bom A, Booij LH. Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeys. Br J Anaesth. 2006;96(2):201-6.

9. Stewart JT. Huntington’s disease. Am Fam Physician. 1988;37(5):105-14.

10. Blobner M, Eriksson L, Scholz J, Hillebrand H, Pompei L. Sugammadex (2 mg/kg) significantly faster reverses shallow rocuronium-induced neuromuscular blockade compared with Neostigmine (50 microgram/kg). Eur J Anaesthesiol. 2007;24(Suppl.39):125-6.

11. Mac Pherson P, Harper I, MacDonald I. Propofol and remifentanil total intravenous anesthesia for a patient with Huntington disease. J Clin Anesth. 2004;16(7):537-8.

12. Kang JM, Chung JY, Han JH, Kim YS, Lee BJ, Yi JW. Anesthetic management of a patient with Huntington's chorea -A case report-. Korean J Anesthesiol. 2013;64(3):262-4.

13. Sriganesh K, Saini J. Exacerbation of involuntary movements after propofol anesthesia in a patient with Huntington disease. J Neurosurg Anesthesiol. 2013;25(2):212-4.

14. Glass PS, Hardman D, Kamiyama Y, Quill TJ, Marton G, Donn KH, Grosse CM, Hermann D. Preliminary pharmacokinetics and pharmacodynamics of an ultrashort acting opioid: remifentanil (GI87084B). Anesth Analg. 1993;77(5):1031-40.